Conclusions: Several existing processes and resources were identified for use in the research context, however these were fragmented and difficult to access systematically. The toolkit brings together these existing processes and resources for member engagement and supplements them with additional principles for engagement. After further testing to understand the toolkit's contribution to project development and completion, it could serve as an example for other HMORN partners for development of similar resources. 
Unit (CCRU) is charged with providing Kaiser Permanente Northern California (KPNC) research investigators pre-award services including industry and non-industry sponsored clinical trial budgeting and proposal preparation. The CCRU provides first-line communication for the Principal Investigator (PI) for feasibility review of study protocols, clinical trial budgets and clinical trial and sponsored research agreements. The purpose of this presentation is two-fold: (1) describe CCRU's comprehensive pre-award services and (2) describe the process and tools employed by the CCRU for developing and negotiating clinical trial budgets. Methods: The CCRU has implemented a pre-award service model in which the CCRU reviews and conducts a comprehensive feasibility assessment of proposed clinical trials, designs a clinical trial budget, directly negotiates the budget with the sponsor, and concludes the budget process by approving (or rejecting) the budget and budget terms. The CCRU Lead Financial Analyst spearheads the budget development and negotiation, and works in tandem with the Revenue group for billing coverage analysis. Post-award functions and Clinical Trial Agreement (CTA) approval are under the auspices of KFRI's Grants and Contracts office. The CCRU employs a budget template, the Site Assessment Survey (SAS) which provides line-item delineations of pass-through costs, per-subject procedures costs, invoiceable charges, staff salaries, and overhead cost. Time and effort analysis, and standard versus research care determinations are performed with PI participation. Procedures costs are based on the most current KPNC Master Fee Schedule. Results: The preaward program offers KPNC investigators a directed and streamlined approach to clinical trial budgeting and other clinical trials operations functions, and helps consolidate clinical research administration overall. The overall pre-award process has yielded more transparent and defensible budgets, conducted in a highly collaborative fashion, with input from the PI, the CCRU management team, Revenue group, and KFRI Grants and Contracts. Conclusions: The CCRU pre-award program provides high quality and timely clinical trial pre-award service that includes study feasibility analysis, Medicare Coverage Analysis, study budget development, and compliance, thus enhancing KPNC clinical research capabilities. The pre-award program is critical to the sustainability and growth of the KPNC research enterprise. Non-compliance findings ran the gamut; from violations related to required regulatory submissions to deviations from written procedures, and failures to maintain study documents. This presentation will: (1) discuss the triggers and types of FDA audit and the procedures necessary to prepare KP investigators and sites for a successful audit, and (2) discuss the approaches to ensure GCP and audit-readiness at all times. A case study of a routine BIMO audit of a KPNC study site participating in an investigational device trial will be presented. 
